Indoco Remedies Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹445.36 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.11 per cent from ₹484.67 crore. This corresponds to a year-on-year *(YoY) growth of 8.48 per cent.
Operating Profit
Operating Profit stands at ₹44.93 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.67 per cent from ₹47.13 crore. This corresponds to a year-on-year *(YoY) growth of 22.73 per cent.
PBDT
PBDT stands at ₹30.15 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.95 per cent from ₹27.93 crore. This corresponds to a year-on-year *(YoY) growth of 15.25 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-31.31 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 131.41 per cent from ₹-13.53 crore. This corresponds to a year-on-year *(YoY) decline of 1.13 per cent.
Net Profit
Net Profit stands at ₹-23.64 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 219.46 per cent from ₹-7.40 crore. This represents a 13.66 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | 2.39% | 1.28% | -6.56% | -19.23% | -27.36% | -1.58% |
| Bliss GVS Pharma | -4.10% | -6.94% | 27.88% | 24.25% | 34.56% | 57.95% |
| IOL Chemicals | -1.47% | -2.94% | 2.80% | -20.54% | -23.96% | 8.04% |
| Panacea Biotec | -1.69% | -5.20% | -3.55% | -2.73% | -16.83% | 4.28% |
| Amrutanjan Healt | 0.90% | -2.76% | 3.32% | -10.53% | -13.76% | 1.75% |
| Solara Active | 0.26% | -1.09% | -7.64% | -9.76% | -24.47% | -3.96% |
| Shukra Pharma. | 4.06% | -4.93% | -12.40% | -6.23% | 55.98% | 75.49% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Non-Exec & Non-Independent Dir : Anand Nadkarni
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN